Biofrontera Inc. (NASDAQ:BFRI) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRI) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 473,800 shares, an increase of 136.2% from the September 30th total of 200,600 shares. Approximately 14.5% of the shares of the company are sold short. Based on an average trading volume of 368,100 shares, the days-to-cover ratio is currently 1.3 days.

Biofrontera Price Performance

Shares of NASDAQ:BFRI opened at $0.91 on Monday. The company’s 50 day simple moving average is $1.09 and its 200 day simple moving average is $1.17. The stock has a market capitalization of $4.62 million, a price-to-earnings ratio of -0.07 and a beta of 0.50. Biofrontera has a 1 year low of $0.61 and a 1 year high of $5.28.

Biofrontera (NASDAQ:BFRI) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($1.12) EPS for the quarter, beating analysts’ consensus estimates of ($1.19) by $0.07. The company had revenue of $7.84 million during the quarter, compared to analysts’ expectations of $9.02 million. Biofrontera had a negative return on equity of 837.97% and a negative net margin of 38.34%. As a group, analysts anticipate that Biofrontera will post -3.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Benchmark reissued a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a report on Friday, August 16th.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.